Intermountain Ventures

Intermountain Ventures is the corporate venture arm of Intermountain Healthcare, established in 2012 and located in Salt Lake City, Utah. The organization specializes in strategic investments and partnerships, focusing on early- and growth-stage innovative companies within the healthcare sector. Intermountain Ventures collaborates with a variety of entities, including corporations, venture capital and private equity firms, technology organizations, and mission-driven organizations, all aimed at advancing health improvements. Through its investments, Intermountain Ventures seeks to drive innovation and enhance healthcare delivery.

Nickolas Mark

Managing Partner and Co-Founder

17 past transactions

Vori Health

Series B in 2025
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.

Qualified Health

Seed Round in 2025
Qualified Health is a technology company specializing in generative artificial intelligence (AI) for healthcare. It provides an infrastructure solution that ensures safe and effective use of AI in medicine, offering features such as continuous algorithm performance monitoring, active AI governance, and customizable AI agents tailored to healthcare needs. The company partners with leading health systems in the U.S. to revolutionize healthcare through AI.

Stepful

Series B in 2024
Stepful is a training platform designed to assist individuals without college degrees in entering the healthcare job market. The company offers a comprehensive curriculum that includes online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to develop hands-on skills, particularly in bloodwork. To further support its users, the platform also includes job placement assistance, helping graduates secure entry-level positions in the healthcare industry and facilitating opportunities for career advancement. By focusing on high school graduates, Stepful aims to fill vacancies in the healthcare sector quickly while reducing hiring costs for employers.

Noetik

Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By leveraging self-supervised learning and integrating human multimodal data, the company aims to enhance the effectiveness and personalization of cancer therapies, thereby improving patient outcomes in oncology.

WellBe Senior Medical

Venture Round in 2024
WellBe Senior Medical, LLC specializes in providing geriatric care services to frail and polychronic seniors, primarily focusing on those with complex, chronic conditions. Founded in 2019 and based in Chicago, the company offers a comprehensive health care program known as Complete Care, which delivers personalized support in various settings, including patients' homes, hospitals, and skilled nursing facilities. The WellBe care team collaborates closely with patients, caregivers, and physicians to address all aspects of health, including physical, social, and emotional well-being. Through its commitment to delivering high-quality care, WellBe aims to enhance the health and quality of life for its clients as they navigate the challenges associated with aging.

Cylinder

Series B in 2023
Founded in 2021, Cylinder delivers personalized, clinician-backed care to those suffering from digestive issues through its virtual health platform and has helped nearly 100K members to date. Cylinder's platform offers dynamically updated content and care plans designed to improve engagement and outcomes. Members enjoy access to a dedicated care team nationwide, including health coaches, registered dietitians, and GI doctors. Cylinder’s vision is to create a world where people receive convenient, personalized, and affordable access to the quality digestive health care they need to improve their overall health. Trusted by businesses including Texas A&M University, US Foods, and more, Cylinder showcases up to 5:1 ROI and an average of 13% employee engagement. Learn more at cylinderhealth.com.

Noetik

Seed Round in 2023
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By leveraging self-supervised learning and integrating human multimodal data, the company aims to enhance the effectiveness and personalization of cancer therapies, thereby improving patient outcomes in oncology.

Octave

Series B in 2023
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company's platform generates, analyzes, and integrates data to provide a comprehensive approach aimed at reducing the overall cost of care. By optimizing healthcare medications and utilization, Octave enables pharmaceutical companies to enhance the entire lifecycle of drug discovery, clinical trials, and post-marketing processes through the use of real-world evidence. This innovative approach seeks to improve patient outcomes while streamlining healthcare practices.

Axuall

Series B in 2023
Axuall, Inc. is a workforce intelligence company that operates a digital network designed to verify identities, credentials, and authenticity across various sectors, including healthcare, insurance, and logistics. Founded in 2018 and based in Cleveland, Ohio, Axuall offers an integrated platform that facilitates smarter decision-making and expedites the onboarding process for healthcare providers. By leveraging real-time practitioner data, the company enhances workforce deployment and efficiency, and provides critical insights for network planning, analytics, and reporting. Its solutions aim to empower healthcare professionals by granting them control over their career identities while connecting health systems, staffing firms, and telehealth organizations to valuable data resources.

Maven Clinic

Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Cylinder

Series A in 2022
Founded in 2021, Cylinder delivers personalized, clinician-backed care to those suffering from digestive issues through its virtual health platform and has helped nearly 100K members to date. Cylinder's platform offers dynamically updated content and care plans designed to improve engagement and outcomes. Members enjoy access to a dedicated care team nationwide, including health coaches, registered dietitians, and GI doctors. Cylinder’s vision is to create a world where people receive convenient, personalized, and affordable access to the quality digestive health care they need to improve their overall health. Trusted by businesses including Texas A&M University, US Foods, and more, Cylinder showcases up to 5:1 ROI and an average of 13% employee engagement. Learn more at cylinderhealth.com.

Axuall

Series A in 2021
Axuall, Inc. is a workforce intelligence company that operates a digital network designed to verify identities, credentials, and authenticity across various sectors, including healthcare, insurance, and logistics. Founded in 2018 and based in Cleveland, Ohio, Axuall offers an integrated platform that facilitates smarter decision-making and expedites the onboarding process for healthcare providers. By leveraging real-time practitioner data, the company enhances workforce deployment and efficiency, and provides critical insights for network planning, analytics, and reporting. Its solutions aim to empower healthcare professionals by granting them control over their career identities while connecting health systems, staffing firms, and telehealth organizations to valuable data resources.

SomaLogic

Series A in 2020
SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

Recursion Pharmaceuticals

Series D in 2020
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.

Gyant

Series A in 2020
GYANT is a digital front door solution for health systems that utilizes artificial intelligence to enhance patient navigation to appropriate care settings and in-network resources. By implementing digital patient journeys, GYANT enables health systems to effectively capture new patients and efficiently serve existing ones. The platform employs natural language processing to understand patients' needs, guiding them through their healthcare encounters. This not only improves patient engagement but also enhances care utilization, leading to better access to healthcare services. Additionally, GYANT contributes to process automation within health systems, ultimately resulting in lower costs and time savings for healthcare providers.

Syapse

Series F in 2020
Syapse, Inc. is a company that develops a precision medicine software platform aimed at improving cancer care through the integration and analysis of diverse clinical, molecular, treatment, and outcomes data. By leveraging real-world evidence, Syapse enables healthcare organizations to collaborate effectively, providing comprehensive patient insights that inform clinical decisions. Its primary offering, the Syapse Learning Health Network, serves as a global data-sharing network that supports oncologists and life sciences collaborators with actionable insights derived from real-world data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse works to enhance precision medicine programs and drive impactful outcomes for cancer patients. The company has also established a strategic partnership with Pfizer to further its mission in the field of precision oncology.

Omada

Corporate Round in 2019
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.